Bionaturis, a biotechnological company which develops and manufactures biological products for human and veterinarian uses and trading in the Spanish MAB Stock Market since last January, has exceeded its forecast. The company closed its fiscal year with a €308,000 profit … Continue reading
9 mayo, 2012
by PressBNT
0 comments


